Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DB26FH
|
|||
| Drug Name |
EO2401
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Adrenocortical carcinoma [ICD-11: 2D11.Z; ICD-9: 194] | Phase 1/2 | [1] | |
| Paraganglioma [ICD-11: 2E92.2] | Phase 1/2 | [1] | ||
| Pheochromocytoma [ICD-11: 5A75; ICD-10: E27.5] | Phase 1/2 | [1] | ||
| Company |
Enterome Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04187404) A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma (Spencer). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.